Private Label Probiotic Sunscreen Manufacturer Low MOQ Guide

What regulatory approvals or claims substantiation do I need before selling private label probiotic sunscreen in different markets?

By Blake Mereby · Last reviewed October 13, 2026

Regulatory requirements for probiotic sunscreen differ substantially by market and hinge on whether you claim the product as a cosmetic, an OTC drug, or a combination. In the United States, sunscreen is classified as an over-the-counter (OTC) drug by the FDA, meaning any sun protection claim (SPF, broad-spectrum, UVA/UVB protection) makes the product a drug and requires compliance with 21 CFR 333.320 (Sunscreen Drug Products for Over-the-Counter Use). You must submit a Drug Master File (DMF) containing your formula, raw material specifications, manufacturing SOP, stability data (minimum 8-12 weeks at 40 °C / 75% RH), and SPF/UVA in-vivo testing data to the FDA before marketing, or register your facility and list your product under 21 CFR 607 (Cosmetic Facility Registration and Product Listing) if you make no drug claims and position the product as a cosmetic only (i.e., moisturizer with sun-protective ingredients, no SPF claim). If you claim probiotic benefits (e.g., "supports skin microbiome," "promotes healthy skin barrier"), these are cosmetic claims and must be truthful and not misleading; you do not need pre-approval, but you must have substantiation (published studies, in-vivo efficacy data, or expert opinion) available for FTC review if challenged. The probiotic ingredient itself must come from a GRAS source (generally recognized as safe) per 21 CFR 182 and 184; most commercial Lactobacillus and Bacillus strains meet this requirement if sourced from a reputable vendor with a safety dossier.

In the European Union, sunscreen is regulated as a cosmetic (not a drug) under the Cosmetics Regulation (EC 1223/2009). UV filter actives (zinc oxide, avobenzone, etc.) must be on the Positive List (Annex VI of the Regulation), and you can use only approved concentrations and combinations. SPF claims are allowed and must be substantiated by in-vitro testing (using COLIPA or JMPR methods) or in-vivo testing; in-vivo data is preferred but not mandatory. The probiotic ingredient must also be permitted: Annex III lists allowed microorganisms (live cells, inactivated cells, and fermentation extracts of specified species are permitted for most uses, though restrictions apply near the eye and lips). A Cosmetic Product Safety Report (CPSR) is required, which includes microbiological risk assessment, stability data, and safety dossier for the probiotic (confirming absence of pathogens and toxins). You do not need pre-approval from the EU's regulatory body, but your product must comply before placing it on the market, and you must notify the CPNP (Cosmetic Products Notification Portal) of your product and submit a CPSR within the required timeframe. The CPSR preparation costs $1,500–$3,000 per product if outsourced to a regulatory consultant.

In Australia, the TGA (Therapeutic Goods Administration) regulates sunscreen as either a cosmetic or a therapeutic good. Sunscreen is generally listed as a cosmetic if it makes only external sun-protection claims; if you claim "promotes skin health" or "supports immune function" alongside SPF, it may be deemed therapeutic and require TGA approval before sale, which involves additional testing and dossier submission (cost: $3,000–$10,000). SPF claims must be substantiated by in-vivo testing; in-vitro data alone is not accepted. Probiotic ingredients are permitted under the Australian Cosmetics Code of Practice if they are non-pathogenic and from an approved source (e.g., Lactobacillus species with a safety dossier).

In Canada, Health Canada's Cosmetic Regulations classify sunscreen as a cosmetic, but SPF and broad-spectrum claims trigger additional substantiation requirements. Any UV-protective claim must be backed by in-vivo or in-vitro SPF testing, and a Natural and Non-prescription Health Products Directorate (NNHPD) submission may be required if you make internal health claims (e.g., "boosts immune function"). Health Canada does not pre-approve cosmetics, but you must maintain a Cosmetic Dossier and be prepared to provide it on request. Probiotic ingredients are permitted if they are non-pathogenic and have a safety dossier.

Key substantiation steps common to all markets:

1. SPF and UVA Broad-Spectrum Testing: In-vivo or in-vitro, typically $2,500–$4,500. In-vivo is globally accepted; in-vitro is cheaper but may not satisfy all regulators (US FDA prefers in-vivo, EU/Canada accept in-vitro).

2. Stability Testing: 8–12 weeks at 40 °C / 75% RH, with testing at baseline, 4 weeks, 8 weeks, and 12 weeks for SPF retention, emulsion stability, probiotic viability, and preservative efficacy. Cost: $1,200–$2,500.

3. Probiotic Safety and Identity: Certificate of analysis (CoA) from the ingredient supplier confirming strain identity (16S rRNA or HPLC), viable cell count, absence of pathogens, and endotoxin levels. If launching as a drug (US) or therapeutic (Australia), add a full safety dossier for the strain, including historical use data and toxicology review. Cost: included in supplier's CoA or $500–$2,000 for a custom dossier.

4. Preservative Efficacy Study (PES): Demonstrates the product resists microbial contamination over its claimed shelf-life. Cost: $800–$1,500, takes 4–6 weeks. Required in the US (if submitting a DMF) and recommended in the EU and Canada.

5. Cosmetic or Drug Master File / CPSR: For the US, a DMF (if making drug claims) or simply listing your product in the Cosmetic Facility database (if cosmetic-only). For the EU, a Cosmetic Product Safety Report. For Canada, a Cosmetic Dossier (maintained on file, not submitted upfront). Cost: $0–$2,000 depending on whether you hire a regulatory consultant or do it in-house.

A critical mistake first-timers make is assuming all markets accept in-vitro SPF testing and posting the same SPF data to the US FDA, EU, Australia, and Canada. The US FDA prefers in-vivo and may reject an application backed only by in-vitro data. Australia's TGA accepts in-vivo but not in-vitro. To be safe, commission in-vivo testing once ($2,500–$4,500) and use those results in all markets. This costs more upfront but de-risks regulatory rejection later.

Another common pitfall: not planning regulatory timelines. If you target the US and the EU, allow 6–8 weeks for stability and SPF testing, 2–4 weeks for CPSR preparation, and 2–4 weeks for FDA review or pre-submission inquiries. Total: 10–16 weeks before launch. Many founders underestimate this and rush to market with incomplete dossiers, leading to FDA warning letters or product seizure.

When engaging a manufacturer via AJ Cosmo Labs, ask: "What regulatory markets does your formula already have approvals or stability data for, and what additional testing would be needed for [my target market]?" Vetted co-packers and chemists often have formulas with US FDA and EU CPSR already in place; reusing those de-risks and shortens your timeline. Always hire a regulatory consultant or ask your manufacturer to include regulatory guidance in your contract; the $1,000–$2,000 cost is far less than a product recall or legal action from consumers or regulators.

Ingredients in this answer: Avobenzone · Zinc Oxide

Read the full guide on Private Label Probiotic Sunscreen Manufacturer Low MOQ Guide →

More about Private Label Probiotic Sunscreen Manufacturer Low MOQ Guide

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app